Quantcast
Don't Miss

Rockville-based Novavax falls short of expectations

Novavax Inc., of Rockville, which is developing vaccines to treat viral infections, reported a fourth-quarter net loss of $8 million, or 6 cents per diluted share, versus a net loss of $3.7 million, or 3 cents per share, in the prior-year period.

Print, Digital & Mobile

Monthly Autorenew
$0.99
(special offer!)

----------
3 Months
$84.00

----------
6 Months
$162.00

----------
1 Year
$269.00


Digital & Mobile Only

1 Year
$169.00

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
Scroll To Top